J Furby

656 total citations
8 papers, 400 citations indexed

About

J Furby is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, J Furby has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 4 papers in Neurology. Recurrent topics in J Furby's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). J Furby is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). J Furby collaborates with scholars based in United Kingdom, Netherlands and Italy. J Furby's co-authors include Robert Brenner, Jeremy Chataway, Daniel R. Altmann, Thomas Hayton, Kenneth J. Smith, David H. Miller, Richard AC Hughes, Raju Kapoor, Ravish Kapoor and Valerie Anderson and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and Journal of Neurology.

In The Last Decade

J Furby

8 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Furby United Kingdom	8	331	119	105	60	56	8	400
S. Alessio Italy	6	330 1.0×	138 1.2×	105 1.0×	62 1.0×	58 1.0×	6	400
D. S. Dougherty United States	4	494 1.5×	199 1.7×	194 1.8×	56 0.9×	71 1.3×	4	553
Valentina Poretto Italy	7	406 1.2×	181 1.5×	118 1.1×	79 1.3×	69 1.2×	12	495
A. Beheshtian United States	4	496 1.5×	237 2.0×	150 1.4×	30 0.5×	67 1.2×	6	584
G. Vacca Italy	14	302 0.9×	132 1.1×	128 1.2×	42 0.7×	68 1.2×	16	482
Uroš Rot Slovenia	12	221 0.7×	137 1.2×	101 1.0×	46 0.8×	82 1.5×	31	524
Alessandra Mattioda Italy	6	295 0.9×	126 1.1×	45 0.4×	72 1.2×	58 1.0×	6	392
Valeria Barletta Italy	13	327 1.0×	77 0.6×	70 0.7×	42 0.7×	32 0.6×	30	448
T. Korteweg Netherlands	6	309 0.9×	133 1.1×	127 1.2×	39 0.7×	44 0.8×	7	346
Lukáš Sobíšek Czechia	11	273 0.8×	89 0.7×	89 0.8×	28 0.5×	49 0.9×	30	346

Countries citing papers authored by J Furby

Since Specialization

Citations

This map shows the geographic impact of J Furby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Furby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Furby more than expected).

Fields of papers citing papers by J Furby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Furby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Furby. The network helps show where J Furby may publish in the future.

Co-authorship network of co-authors of J Furby

This figure shows the co-authorship network connecting the top 25 collaborators of J Furby. A scholar is included among the top collaborators of J Furby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Furby. J Furby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Gnanapavan, Sharmilee, Donna Grant, S. V. Morant, et al.. (2013). Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression. PLoS ONE. 8(8). e70019–e70019. 42 indexed citations

Hayton, Thomas, J Furby, Kenneth J. Smith, et al.. (2011). Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis. Journal of Neurology. 259(2). 237–245. 16 indexed citations

Hayton, Thomas, J Furby, Kenneth J. Smith, et al.. (2011). Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. Journal of Neurology. 259(3). 505–514. 22 indexed citations

Furby, J, Thomas Hayton, Daniel R. Altmann, et al.. (2010). A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. Journal of Neurology. 257(9). 1508–1516. 36 indexed citations

Kapoor, Raju, J Furby, Thomas Hayton, et al.. (2010). Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. The Lancet Neurology. 9(7). 681–688. 183 indexed citations

Hayton, Thomas, J Furby, Kenneth J. Smith, et al.. (2009). Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. Journal of Neurology. 256(3). 427–435. 23 indexed citations

Furby, J, Thomas Hayton, Daniel R. Altmann, et al.. (2009). Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 15(6). 687–694. 11 indexed citations

Furby, J, Thomas Hayton, Valerie Anderson, et al.. (2008). Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 14(8). 1068–1075. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact